Trademarkia Logo

Canada

C$
LASATO
REGISTERED

on 5 Jul 2019

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 92500 Valby

DK

Serial Number

1847782 filed on 17th Jul 2017

Registration Number

TMA1036795 registered on 5th Jul 2019

Registration expiry Date

5th Jul 2029

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

LASATO

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or ac Read More

Classification Information


Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, ADHD, cancer, migraine, pain, alcoholism and dependency; diagnostic reagents and agents for medical diagnostic use.


Classification kind code

11

Mark Details


Serial Number

1847782

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 55
on 5th Jul 2019
Registered
Submitted for opposition 50
on 7th Dec 2018
Allowed
Submitted for opposition 51
on 7th Dec 2018
Allowance Notice Sent
Submitted for opposition 42
on 22nd Aug 2018
Advertised
Submitted for opposition 26
on 16th Aug 2018
Approved
Submitted for opposition 22
on 28th Jun 2018
Search Recorded
Submitted for opposition 27
on 28th Jun 2018
Approval Notice Sent
Submitted for opposition 31
on 24th Jul 2017
Formalized
Submitted for opposition 1
on 18th Jul 2017
Created
Submitted for opposition 30
on 17th Jul 2017
Filed